Jiu Lin Selected Research

Chemokines

2/2022

C-X-C motif chemokine ligand 1 and its receptor C-X-C motif chemokine receptor 2 in trigeminal ganglion contribute to nerve injury-induced orofacial mechanical allodynia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jiu Lin Research Topics

Disease

11	Pain (Aches) 09/2022 - 01/2019
9	Neuralgia (Stump Neuralgia) 12/2023 - 11/2019
8	Hyperalgesia 01/2023 - 01/2019
5	Facial Pain (Myofacial Pain) 01/2022 - 01/2019
3	Hypersensitivity (Allergy) 09/2022 - 01/2020
3	Inflammation (Inflammations) 01/2020 - 01/2019
2	Trigeminal Nerve Injuries 12/2023 - 09/2022
2	Ganglion Cysts (Ganglion) 01/2020 - 02/2019
1	Chronic Pain 01/2021
1	Fibrosarcoma 01/2020
1	Necrosis 10/2019

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 12/2023 - 12/2019
3	Protein Kinase CIBA 12/2023 - 01/2020
3	chelerythrineIBA 12/2023 - 01/2020
3	CytokinesIBA 09/2022 - 10/2019
3	Purinergic Receptors (Receptors, Purine)IBA 09/2022 - 11/2019
3	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2022 - 01/2021
3	Freund's AdjuvantIBA 01/2022 - 01/2019
2	Uridine Diphosphate Glucose (UDP Glucose)IBA 09/2022 - 11/2019
2	Messenger RNA (mRNA)IBA 01/2022 - 01/2020
2	NMDA receptor A1IBA 01/2021 - 01/2021
2	Glutamic Acid (Glutamate)FDA Link 01/2021 - 01/2021
2	Substance PIBA 01/2020 - 10/2019
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2020 - 10/2019
2	U 0126 (UO 126)IBA 01/2020 - 10/2019
2	Glial Fibrillary Acidic ProteinIBA 12/2019 - 10/2019
2	InterleukinsIBA 10/2019 - 01/2019
1	AcidsIBA 12/2023
1	Phosphotransferases (Kinase)IBA 12/2023
1	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 01/2023
1	Activating Transcription Factor 3IBA 09/2022
1	SB 225002IBA 02/2022
1	Chemokine ReceptorsIBA 02/2022
1	LigandsIBA 02/2022
1	ChemokinesIBA 02/2022
1	Long Noncoding RNAIBA 01/2022
1	Circular RNAIBA 01/2022
1	Competitive Endogenous RNAIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Calcium-Calmodulin-Dependent Protein KinasesIBA 01/2022
1	MicroRNAs (MicroRNA)IBA 01/2022
1	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 01/2022
1	Ionotropic Glutamate ReceptorsIBA 01/2022
1	L 368899IBA 01/2021
1	Memantine (Namenda)FDA Link 01/2021
1	N-Methylaspartate (NMDA)IBA 01/2021
1	Calcitonin Gene-Related PeptideIBA 01/2021
1	Oxytocin Receptors (Oxytocin Receptor)IBA 01/2021
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2021
1	Sorafenib (BAY 43-9006)FDA Link 01/2020
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 01/2020
1	protein kinase modulatorIBA 01/2020
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2019
1	CC ChemokinesIBA 12/2019
1	Mitogen-Activated Protein Kinase 3IBA 12/2019
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 11/2019
1	Uridine Diphosphate (UDP)IBA 11/2019
1	Uridine Diphosphate SugarsIBA 11/2019
1	MAP Kinase Kinase Kinases (MAP Kinase Kinase Kinase)IBA 10/2019
1	Mitogen-Activated Protein KinasesIBA 10/2019
1	SB 203580IBA 10/2019
1	Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA 10/2019
1	TitaniumIBA 02/2019
1	Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA 02/2019
1	p38 Mitogen-Activated Protein KinasesIBA 01/2019
1	Baclofen FDA LinkGeneric 01/2019

Therapy/Procedure

1	Therapeutics 01/2022